HMHiromitsu Maehira

Hiromitsu Maehira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hiromitsu Maehira has a total of 143 co-authors. Here are the top co-authors by number of shared publications:

  • Haruki Mori

    Department of Gastrointestinal and General Surgery, Shiga University of Medical Science, Otsu, Japan

    31 shared publications
  • Masaji Tani

    Department of Gastrointestinal and General Surgery, Shiga University of Medical Science, Otsu, Japan

    28 shared publications
  • Takeru Maekawa

    Department of Gastrointestinal and General Surgery, Shiga University of Medical Science, Otsu, Japan

    21 shared publications
  • Toru Miyake

    Department of Gastrointestinal and General Surgery, Shiga University of Medical Science, Otsu, Japan

    21 shared publications
  • Sachiko Kaida

    Department of Gastrointestinal and General Surgery, Shiga University of Medical Science, Otsu, Japan

    20 shared publications
  • Katsushi Takebayashi

    Department of Gastrointestinal and General Surgery, Shiga University of Medical Science, Otsu, Japan

    19 shared publications

Latest Publications

  • Open Access

    Modified prophylactic drainage strategy and postoperative pancreatic fistula-related complications after pancreaticoduodenectomy: a single-center retrospective historical cohort study

    by Hiromitsu Maehira, Haruki Mori, Nobuhito Nitta, Takeru Maekawa, Takeshi Sonoda, Katsushi Takebayashi, Masatsugu Kojima, Sachiko Kaida, Toru Miyake, Masaji Tani

  • Open Access

    Safe hepatectomy in patients with constitutional indocyanine green excretory defect: two case reports highlighting multimodal functional assessment

    by Toshiki Eryu, Haruki Mori, Hiromitsu Maehira, Nobuhito Nitta, Toru Miyake, Sachiko Kaida

    Introduction and importance: Constitutional indocyanine green (ICG) excretory defect is a rare condition characterized by markedly impaired ICG clearance despite preserved conventional liver function. This discrepancy makes the preoperative assessment of hepatic functional reserve difficult. We report two patients with hepatocellular carcinoma (HCC) and constitutional ICG excretory defect who underwent hepatectomy based on multimodal functional assessment. Case presentation: Case 1 was a 71-year-old man with a 40-mm HCC involving segments 5 and 8. The indocyanine green retention rate at 15 minutes (ICGR15) was 94.3%, whereas other liver function tests were preserved. Galactosyl human serum albumin (GSA) scintigraphy and fibrosis-related markers supported adequate hepatic reserve, and right anterior sectionectomy was safely performed. Case 2 was an 80-year-old man with a 30-mm recurrent HCC in segment 4, contacting the middle hepatic vein. Although ICGR15 was markedly elevated at 80.0%, conventional liver function tests and GSA scintigraphy suggested acceptable hepatic reserve. Extended left hepatectomy was performed without postoperative liver failure. Clinical discussion: These cases illustrate that markedly elevated ICGR15 does not necessarily indicate impaired hepatic functional reserve in patients with a constitutional ICG excretory defect. When ICGR15 is disproportionately elevated relative to conventional liver function, alternative assessment methods are required. GSA scintigraphy may help guide surgical decision-making in this rare condition. Conclusion: A constitutional ICG excretory defect should be suspected when ICGR15 is markedly elevated despite preserved liver function. In selected patients, hepatectomy may be feasible when the surgical indication is determined using multimodal functional assessment, particularly GSA scintigraphy.

  • A case of a pancreatic pseudocyst associated with alcoholic chronic pancreatitis that mimicked a mucinous cystic neoplasm

    by Koji Takao, Hiromitsu Maehira, Haruki Mori, Nobuhito Nitta, Takeru Maekawa, Katsushi Takebayashi, Masatsugu Kojima, Sachiko Kaida, Toru Miyake, Masaji Tani

    Distinguishing true cysts from pseudocysts can be challenging in clinical practice. We report a patient with a pancreatic pseudocyst secondary to alcoholic chronic pancreatitis that closely mimicked a mucinous cystic neoplasm. A 64-year-old woman with a medical history of alcoholic liver cirrhosis had a progressively enlarging pancreatic cyst in the pancreas body associated with elevated serum carbohydrate antigen 19 − 9 levels. Computed tomography indicated a multilocular cystic lesion with calcification, thickened septa, and protruded lesion. Endoscopic ultrasonography revealed a protruded lesion within the cyst showing detectable blood flow and the cystic lesion had no communication with the main pancreatic duct. Endoscopic ultrasonography showed honeycombing lobularity and strand-like hyperechoic structures in the pancreatic parenchyma. We determined a mucinous cystic neoplasm diagnosis, which cannot rule out malignancy. Distal pancreatectomy with splenectomy was performed. The histopathological examination revealed fibrosis within the pancreatic parenchyma surrounding the cyst as well as fibrin and material suggestive of pancreatic stones along the inner wall. The pancreatic duct was communicated with the cyst and epithelial lining of the cyst wall was not identified, leading to a pancreatic pseudocyst diagnosis. Even when MCN-like features are present in patients with chronic pancreatitis as an underlying disease, it is difficult to completely rule out pancreatic pseudocysts.

  • Impact of the fibrosis-4 index on postoperative complications in patients undergoing laparoscopic liver resection

    by Nobuhito Nitta, Hiromitsu Maehira, Haruki Mori, Takeshi Sonoda, Takeru Maekawa, Masatsugu Kojima, Soichiro Tani, Reiko Otake, Katsushi Takebayashi, Toru Miyake, et al.

    Background The objective of this study was to evaluate the relationship between preoperative fibrosis-4 (FIB-4) index and postoperative complications in the patients undergoing laparoscopic liver resection (LLR) for liver tumors. Methods The 196 patients undergoing LLR were retrospectively analyzed. The patients with the FIB-4 index over 2.67 were classified as the high FIB-4 group. Clinicopathological characteristics and the incidence of postoperative major complications were compared between the high FIB-4 and standard groups. Inverse probability of treatment weighting (IPTW) analysis using propensity scores was performed to minimize selection bias in comparisons between the two groups. Results Among the 196 patients, 92 (47%) were classified into the high FIB-4 group, and the remaining 104 (53%) were classified into the standard FIB-4 group. Postoperative major complications developed in 20 patients (10%). Multiple indicators of liver function and liver fibrosis were significantly worse in the high FIB-4 group. Blood loss per unit liver transection area and operation time per unit liver transection area were significantly greater in the high FIB-4 group (p = 0.009 and p = 0.004, respectively). The incidence of major postoperative complications was significantly higher in the high FIB-4 group (p = 0.009). These differences remained significant after IPTW adjustment. Conclusions A high FIB-4 index was significantly associated with increased intraoperative blood loss and a higher incidence of postoperative complications following LLR.

  • Impact of CT-Based Body Composition Analysis on Postoperative Survival in Patients Undergoing Colorectal Cancer Surgery

    by Masatsugu Kojima, Toru Miyake, Soichiro Tani, Shigeki Bamba, Keiji Muramoto, Yusuke Nishina, Sachiko Kaida, Katsushi Takebayashi, Hiromitsu Maehira, Reiko Otake, et al.

    Background: Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, underscoring the need for reliable prognostic biomarkers. Emerging evidence suggests that body composition parameters may influence cancer outcomes. This study aimed to evaluate whether low skeletal muscle mass, high visceral fat, and their coexistence predict long-term outcomes in patients with CRC. Methods: This retrospective study included 103 patients with pathological stage III CRC who underwent curative resection. Skeletal mass index (SMI) and visceral fat index (VFI) were calculated from preoperative CT images at the L3 level by dividing skeletal muscle and visceral fat areas by height squared. Overall survival (OS) and recurrence-free survival (RFS) were analyzed using Kaplan-Meier and Cox regression models. Results: Low-SMI and high-VFI were present in 52.4% and 28.2% of patients, respectively. In Cox regression, low-SMI independently predicted poor OS (HR 5.14, P = 0.004), while high-VFI was an independent predictor of RFS (HR 2.72, P = 0.012). In the four-group analysis, for OS, both the coexistence of low-SMI and high-VFI (low-SMI-high-VFI, P = 0.021) and low-SMI-only ( P = 0.023) had worse survival than controls, with no difference between them ( P = 0.77). For RFS, high-VFI alone was associated with worse prognosis compared with controls ( P = 0.040). Low-SMI-high-VFI patients had significantly poorer prognosis than both controls ( P < 0.001) and low-SMI alone ( P = 0.024). Conclusions: Low skeletal muscle mass and high visceral fat are associated with poorer OS and RFS, respectively. The coexistence of them may have an additive adverse association with recurrence risk in patients with low skeletal muscle mass. Preoperative body composition assessment may facilitate risk stratification in CRC, and improving these parameters could potentially contribute to better oncologic outcomes.

  • Clinical Features of Postoperative Pancreatic Fistula After Pancreaticoduodenectomy in Patients With a Hard Pancreas: Focused on Estimated Functional Remnant Pancreatic Volume

    by Hiromitsu Maehira, Nobuhito Nitta, Haruki Mori, Takeru Maekawa, Takeshi Sonoda, Reiko Otake, Soichiro Tani, Katsushi Takebayashi, Masatsugu Kojima, Sachiko Kaida, et al.

    Background: This study aimed to evaluate the association between computed tomography (CT) findings and the development of postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD) in patients with a hard pancreas. Methods: The medical records of 96 patients who underwent PD and had a hard pancreas were retrospectively reviewed. The estimated functional remnant pancreatic volume (eFRPV), which is a composite preoperative CT-derived parameter reflecting both pancreatic volume and attenuation, was evaluated. Additionally, pancreatic attenuation value (PAV), remnant pancreatic volume (RPV), and main pancreatic duct (MPD) were also assessed. Variables, including eFRPV, were compared between patients with and those without POPF after PD. Results: Clinically relevant POPF was observed in seven (7.3%) patients. In the preoperative evaluable factors, only the eFRPV (33.3 HU·mL vs 70.8 HU·mL, P = .021) and PAV (32.6 HU vs 40.2 HU, P = .013) were associated with clinically relevant POPF. Remnant pancreatic volume and MPD were not significantly different between two groups. The area under the curve (AUC) was 0.764 for eFRPV and 0.783 for PAV. Although the AUCs for eFRPV and PAV were not significantly different ( P = .785), eFRPV showed higher specificity at the point corresponding to 100% sensitivity (62.5% vs 38.2%). Conclusions: In patients with a hard pancreas, POPF following PD can be predicted using eFRPV assessed by preoperative CT.

  • Open Access

    Giant splenic cyst over 17 cm with elevation of serum CA19-9 levels treated by hand-assisted laparoscopic splenectomy: a case report

    by Hiromitsu Maehira, Haruki Mori, Nobuhito Nitta, Sachiko Kaida, Toru Miyake, Masaji Tani

    Introduction and importance: Splenic cysts are rare, with a reported incidence of 0.07–0.3%. Although most cases are benign and asymptomatic, some may grow large, rupture, become infected, or cause internal hemorrhage. Elevated serum carbohydrate antigen 19-9 (CA19-9) levels may also be observed, raising concerns regarding malignancy. Nonetheless, their diagnosis remains challenging because of their rarity, and the optimal treatment strategy remains controversial. Herein, we report a case of a giant splenic epithelial cyst with elevated serum CA19-9 levels that was successfully treated with laparoscopy-assisted splenectomy. Presentation of case: We present the case of a 34-year-old female with a giant splenic epithelial cyst measuring >17 cm in diameter associated with elevated serum CA19-9 levels (122 U/mL). The cyst was initially discovered incidentally during imaging studies 3 years prior but had increased significantly in size. Recently, imaging revealed a multilocular cystic lesion with septations that prompted surgical resection owing to concerns of malignancy. Laparoscopic-assisted splenectomy was performed using a hand-assisted technique, following laparoscopic management of the splenic hilum. The cystic fluid CA19-9 level was markedly elevated at 10 832 U/mL; however, histopathology revealed a benign epithelial cyst. The postoperative recovery was uneventful, and the serum CA19-9 level normalized (8 U/mL) within 1 month. Three years after surgery, there were no signs of recurrence or complications. Clinical discussion: Splenic cysts are considered challenging to diagnose because splenic cysts are not common. However, proper management is needed. In cases of giant splenic cysts, pure laparoscopic surgery without rupture of the cyst presents challenges in accessing and dissecting the cranial side of the spleen owing to limited instrument maneuverability. In contrast, a planned hand-assisted approach may ensure safe and complete removal of the cyst without intraoperative rupture and spillage. Conclusion: Giant splenic cysts accompanied by elevated CA19-9 levels are rare and pose a diagnostic challenge. Laparoscopy-assisted splenectomy offers a safe and effective approach for complete resection while minimizing the risk of intraoperative rupture and spillage.

  • Open Access

    Assessment of gastric emptying using 13C-acetate breath test with semi-solid diet after gastric cancer surgery and strategies for nutritional guidance

    by Sachiko Kaida, Katsushi Takebayashi, Mika Kurihara, Reiko Otake, Haruki Mori, Hiromitsu Maehira, Toru Miyake, Shigeki Bamba, Hajime Ishikawa, Masaji Tani

  • Open Access

    Predictive Factors for Infectious Complications after Robotic Gastrectomy for Gastric or Esophagogastric Junction Cancer

    by Sachiko Kaida, Katsushi Takebayashi, Reiko Otake, Asuka Fukuo, Nobuhito Nitta, Haruki Mori, Hiromitsu Maehira, Masatsugu Kojima, Toru Miyake, Masaji Tani

    Introduction: Robotic gastrectomy offers perioperative advantages such as reduced blood loss and faster recovery; however, infectious complications remain a significant concern. In this study, we aimed to identify the predictive factors for postoperative infectious complications following radical robotic gastrectomy in patients with gastric or esophagogastric junctional cancer. Methods: This retrospective single-center study analyzed data from 155 patients with gastric or esophagogastric junction cancer who underwent curative robotic gastrectomy between December 2017 and April 2025 to identify predictive factors for postoperative infectious complications. Twenty-two variables, including nutritional indices and surgical factors, were evaluated. Results: A total of 18 patients developed Clavien-Dindo grade II–IIIa infectious complications. Infectious complications included pneumonia (n = 5, 3.2%), intra-abdominal abscess (n = 5, 3.2%), anastomotic leakage (n = 3, 1.9%), cholecystitis (n = 2, 1.2%), nonocclusive mesenteric ischemia (n = 1, 0.6%), bile leakage (n = 1, 0.6%), and sepsis (n = 1, 0.6%). The number of patients with complications and American Society of Anesthesiologists Physical Status (ASA-PS) class ≥3 (p = 0.006) and preoperative smoking (p = 0.012) was higher than that among patients without complications. Although hemoglobin levels (p = 0.041) and lymphocyte-to-monocyte ratios (p = 0.017) were lower in patients with complications, the platelet-to-lymphocyte ratios (p = 0.034) were higher. Multivariate analysis revealed that current smoking (odds ratio, 3.21; 95% confidence interval, 1.24–18.21) and ASA-PS class of ≥3 (odds ratio, 3.8; 95% confidence interval, 1.18–7.52) were identified as predictors of infectious complications. Conclusion: Robotic gastrectomy offers technical advantages, but optimizing patient-specific risk is essential for the best outcomes. Preoperative smoking and a high ASA-PS class were independent predictors of infectious complications following robotic gastrectomy. Enhanced perioperative management targeting these risk factors may reduce postoperative morbidity.